RxDoctor Payments Data

Felicia Beth Stella, MD

Obstetrics · Mobile, ALNPI 1689863938

Payments from drug & device makers

What this record shows

This record is dominated by education: $6,000 of the $7,953 with a category attached, or 75.4%. Intuitive Surgical accounts for 98.5% of it on its own, with 5 other manufacturers making up the rest. 2025 is the largest year on record at $6,752, more than ten times the $18 reported in 2021.

$7,953in general payments, 2019–2025

Across 20 payments — averaging $397.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$8K
  • Applied Medical Resources Corporation$48
  • Organon$28
  • Mayne Pharma Commercial LLC$19
  • Ascend Therapeutics US, LLC$18
  • Meditrina$9

What the payments were for

  • Travel & lodging$1,75022%
  • Food & beverage$1852%
  • Education$6,00075%
  • Gifts$180%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Intuitive Surgical15$7,831
Applied Medical Resources Corporation1$48
Organon1$28
Mayne Pharma Commercial LLC1$19
Ascend Therapeutics US, LLC1$18
Meditrina1$9

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few obstetrics providers in Alabamato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$103,289
Medicare patients
234
Services billed
5,334

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ProliaDenosumab37$63,803
MyrbetriqMirabegron40$44,858
GemtesaVibegron18$15,705
Estradiol147$11,019
PremarinEstrogens, Conjugated24$9,424
ValacyclovirValacyclovir Hcl98$4,033
Estradiol (Twice Weekly)Estradiol20$2,531
Nystatin135$2,267
Clobetasol Propionate48$2,245
Raloxifene Hcl42$1,774
Alendronate Sodium128$1,479
SynthroidLevothyroxine Sodium12$1,427
Methenamine Hippurate25$1,369
ProgesteroneProgesterone, Micronized19$1,105
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst60$905

Paid to pharmacies, not to this prescriber.

Other obstetrics in Mobile

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →